Skip to content
Open access

Implementing pharmacogenomics for LAI antipsychotics

Oct 2026 · The Brown University Psychopharmacology Update · Vol 37 · 0 citations · 1 references

Abstract

Differences among individuals in drug exposure and response are well‐known variables for practicing clinicians. Over the last few decades, investigators have begun to present evidence for how pharmacogenetic strategies might optimize treatment for patients based on their genetic determinants of drug efficacy and toxicity.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.